*Department of Mental Hygiene, and ¶Center on Aging & Health, The Johns Hopkins University School of Public Health, Baltimore, Maryland, U.S.A.; †Department of Psychology and **Department of Family & Human Development, Utah State University, Logan, Utah, U.S.A.; ‡Bryan Alzheimer Disease Research Center/Division of Neurology, Duke University Medical Center, Durham, North Carolina, U.S.A.; §Department of Epidemiology, The Johns Hopkins University of Public Health, Baltimore, Maryland, U.S.A.
Drs. Breitner and Welsh-Bohmer have royalty interests in U.S. Patents #05643960 and #06025395, which cover the use of H2RAs for the prevention of AD onset, or for mitigation of cognitive decline in symptomatic individuals.
Received October 6, 2000.
Accepted May 24, 2001.
Address correspondence and reprint requests to Michelle C. Carlson, PhD, Department of Mental Hygiene & Center on Aging and Health, 2024 E. Monument St., Suite 2-700, Baltimore, MD 21205, U.S.A.; e-mail: [email protected]
